SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    M H Lopes, T G Santos, B R Rodrigues, N Queiroz-Hazarbassanov, I W Cunha, A P Wasilewska-Sampaio, B Costa-Silva, F A Marchi, L F Bleggi-Torres, P I Sanematsu, S H Suzuki, S M Oba-Shinjo, S K N Marie, E Toulmin, A F Hill, V R Martins, Disruption of prion protein–HOP engagement impairs glioblastoma growth and cognitive decline and improves overall survival, Oncogene, 2014,

    CrossRef

  2. 2
    Lin Zhou, Yulong Shang, Changhao Liu, Jinge Li, Hao Hu, Cong Liang, Yanan Han, Wei Zhang, Jie Liang, Kaichun Wu, Overexpression of PrPc, combined with MGr1-Ag/37LRP, is predictive of poor prognosis in gastric cancer, International Journal of Cancer, 2014, 135, 10
  3. 3
    Yinxing Liu, Misty R. Gilbert, Natasha Kyprianou, Vivek M. Rangnekar, Craig Horbinski, The tumor suppressor prostate apoptosis response-4 (Par-4) is regulated by mutant IDH1 and kills glioma stem cells, Acta Neuropathologica, 2014, 128, 5, 723

    CrossRef

  4. 4
    Baohui Liu, Qianxue Chen, Daofeng Tian, Liquan Wu, Huimin Dong, Junmin Wang, Baowei Ji, Xiaonan Zhu, Qiang Cai, Long Wang, Shenqi Zhang, BMP4 reverses multidrug resistance through modulation of BCL-2 and GDNF in glioblastoma, Brain Research, 2013, 1507, 115

    CrossRef

  5. 5
    Sergio Comincini, Giulia Allavena, Silvia Palumbo, Martina Morini, Francesca Durando, Francesca Angeletti, Luigi Pirtoli, Clelia Miracco, microRNA-17 regulates the expression of ATG7 and modulates the autophagy process, improving the sensitivity to temozolomide and low-dose ionizing radiation treatments in human glioblastoma cells, Cancer Biology & Therapy, 2013, 14, 7, 574

    CrossRef

  6. 6
    Rosalyn B Irby, Christina LB Kline, Par-4 as a potential target for cancer therapy, Expert Opinion on Therapeutic Targets, 2013, 17, 1, 77

    CrossRef